JSR Corporation (E01003) Stock Price

JSR Corporation and its group companies operate across a wide range of business segments, including semiconductor materials, display materials, edge computing, life sciences, synthetic resins, and other operations. In the Digital Solutions business, the company handles lithography materials (photoresists and multilayer materials), packaging materials, cleaning agents, CMP materials, color liquid crystal display materials, organic EL display materials, heat-resistant transparent resins, functional films, and stereolithography. This segment includes subsidiaries such as JSR Micro N.V., JSR Micro, Inc., Inpria Corporation, and JSR Micro Korea Co., Ltd.

The Life Sciences business provides diagnostic and research reagents and materials, bioprocess materials, and drug discovery support services. Companies in this segment include Institute for Medical Science Research, KBI Biopharma, Inc., Selexis SA, and Crown Bioscience International.

The Synthetic Resins business manufactures synthetic resins including ABS resin, AES resin, AS resin, and ASA resin, with Techno UMG Corporation and Japan Coloring Corporation as major operating companies.

Other business segments include acrylic emulsions and waterproofing materials, with E-Tech Corporation operating in this field.

On April 1, 2022, JSR Corporation transferred its elastomer business to Japan Synthetic Rubber Spin-off Preparation Corporation, followed by a share transfer to ENEOS Corporation, resulting in the company's exit from the elastomer business. This resulted in a decrease of 13 subsidiaries and 3 affiliated companies.

JSR Corporation is built on the corporate philosophy "Materials Innovation – creating value through materials and contributing to human society (people, communities, and the environment)." The company aims for sustainable growth and value creation for all stakeholders. JSR has designated its Digital Solutions business and Life Sciences business as core operations, with targets for fiscal 2024 of over 300 billion yen in revenue from these two businesses, record-high profits, and a return on equity (ROE) of 10% or more across the company. The company also pursues continuous value creation through maximizing returns on invested capital (ROIC), improving operational efficiency, and maintaining transparency and sound governance.

In the Digital Solutions business, JSR focuses on semiconductor materials for cutting-edge processes, with emphasis on EUV photoresist for nanometer-generation and beyond technologies to expand global market share. In the Life Sciences business, the company aims to improve revenue and profit margins by expanding new contract manufacturing (CDMO) business and growing competitive contract research (CRO) services.

As business conditions remain uncertain, JSR is strengthening its business structure and management framework to become a company with both resilience and sustainability. This includes efforts in growth businesses involving active research and development and business investments. Additionally, addressing ESG issues and strengthening crisis management are key elements of the company's growth strategy. Through these initiatives, JSR is working toward medium- to long-term growth and enhanced corporate value.